Lilly World's Best-Selling Drug: Is the Stock a Buy Now?
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Uncover various ways to earn income without committing to a 9 to 5 job. These options provide the flexibility to work on your terms.
21,829 articlesEli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Weekly data show pending sales remain higher year over year while total housing inventory trends near negative, signa...
Bitcoin has kicked off a broader market move, and a noted analyst believes altcoins could surge 100-300% if momentum ...
Bank Of America boosts its Affirm Holdings target to $88 after a solid quarter, framing May 12 investor day as a cata...
A quiet, strategic move by a bank’s wealth management arm adds more exposure to its parent company’s stock. Learn wha...
Palantir delivers a strong Q1, beating expectations with better profitability than many software peers, yet the stock...
As Uber eyes profitability, a multi-year bull case hinges on margin expansion and stronger bookings. This analysis ou...
SunPower's Q1 2026 results could set the tone for the year. This guide explains what to watch, which numbers matter, ...
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
The Senate Banking Committee advances toward Thursday's CLARITY Act markup amid a surge of amendments and lobbying, s...
A longtime i’m berkshire hathaway investor shifts view on Greg Abel, arguing his disciplined capital allocation and r...
Two data-focused tech players, Palantir and BigBear.ai, report quarterly numbers that investors watch closely. This g...